Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism

Oncotarget
Yong LiuXianping Huang

Abstract

Platinum-based chemotherapeutic drugs are irreplaceable for the treatment of advanced non-small cell lung cancer (NSCLC). However, acquired drug resistance has become a major obstacle for the clinical application of chemotherapy on NSCLC. In the present study, we established carboplatin-resistant NSCLC models on A549 and PC9 cell lines, which were named A549/R and PC9/R. Besides the low sensitivity of A549/R and PC9/R to carboplatin treatment, they exhibited higher metabolism rate of glucose compared to their parental A549 and PC9 cells, respectively. Mechanically, we confirmed that overexpression of PKM2 in A549/R and PC9/R was responsible for the high glucose metabolism and carboplatin resistance. Metformin, an antidiabetic drug, was observed to increase the sensitivity of carboplatin-resistant NSCLC cells to carboplatin treatment in vitro and in vivo. Mechanically, metformin decreased expression of PKM2 and subsequently inhibited the glucose uptake, lactate generation and ATP production in A549/R and PC9/R. Therefore, metformin promoted carboplatin-induced apoptosis through the mitochondria pathway. In addition, we demonstrated that metformin treatment also impaired the cross-resistance of A549/R and PC9/R to cisplatin, etop...Continue Reading

References

Oct 10, 2002·British Journal of Cancer·J Cosaert, E Quoix
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander V KabanovValery Yu Alakhov
Feb 24, 1956·Science·O WARBURG
Nov 10, 2004·Genomics·B Altenberg, K O Greulich
Feb 22, 2005·Current Medicinal Chemistry. Anti-cancer Agents·Pascal Sève, Charles Dumontet
May 24, 2005·Seminars in Cancer Biology·Sybille MazurekErich Eigenbrodt
Mar 6, 2007·Critical Reviews in Oncology/hematology·David J Stewart
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
Feb 20, 2009·Current Treatment Options in Oncology·Rachel E Sanborn
May 16, 2009·Expert Opinion on Drug Metabolism & Toxicology·Michelle A T HildebrandtXifeng Wu
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Oct 27, 2010·Pharmacotherapy·M Shawn McFarland, Rebecca Cripps
Apr 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio RossiSiow-Ming Lee
Dec 22, 2012·Future Medicinal Chemistry·Shijun WenPeng Huang
Jan 30, 2014·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Sarah Fernandes TeixeiraLeticia Batista Azevedo Rangel
Mar 20, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Li LiYong He
Jun 4, 2014·CA: a Cancer Journal for Clinicians·Carol E DeSantisAhmedin Jemal
Nov 18, 2014·The Cochrane Database of Systematic Reviews·Zu-Yao YangJin-Ling Tang
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Sep 13, 2015·Endocrine-related Cancer·Athanasios BikasVasyl Vasko
Nov 23, 2016·Targeted Oncology·Gillian M Keating
Jan 4, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Wei XieKebin Zhang
Jan 6, 2017·Cancer Prevention Research·Donna E SeabloomFrank G Ondrey

❮ Previous
Next ❯

Citations

Dec 4, 2019·Oncology Letters·Qiongli SuXiaoping Yang
May 28, 2020·Frontiers in Cell and Developmental Biology·Alvaro Gonzalez-RajalAndrew Burgess
May 16, 2020·International Journal of Molecular Sciences·Vikas Bhardwaj, Jun He
Nov 21, 2018·Frontiers in Oncology·Esther A Zaal, Celia R Berkers
Feb 23, 2019·Journal of Cellular Biochemistry·Zhuang LuoShaoqing Shi
Oct 31, 2020·Cellular Oncology (Dordrecht)·Ali Fatehi Hassanabad, Kelsey T MacQueen
Oct 24, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jiaqi LiAndrea L A Wong
Apr 28, 2020·Life Sciences·Bin ZhaoPeng Shang
Jun 9, 2021·Life Sciences·Abu Sufiyan Chhipa, Snehal Patel
Aug 18, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Andreia ValentePetra Heffeter
Sep 25, 2021·Cancer & Metabolism·Kasey R CargillLauren A Byers
Dec 29, 2021·Molecular Carcinogenesis·Graham H ReadAparna H Kesarwala

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
flow cytometry
PCR
ELISA
electrophoresis
Assay

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.